SNAPC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.63230540195514E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.54347670597599E-12 |
Normal-vs-Stage2 |
2.08250000000021E-05 |
Normal-vs-Stage3 |
3.229300E-04 |
Normal-vs-Stage4 |
1.397710E-03 |
Stage1-vs-Stage2 |
8.969800E-01 |
Stage1-vs-Stage3 |
2.522800E-01 |
Stage1-vs-Stage4 |
6.888400E-01 |
Stage2-vs-Stage3 |
4.554200E-01 |
Stage2-vs-Stage4 |
6.346600E-01 |
Stage3-vs-Stage4 |
3.123200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.67029739933855E-11 |
Normal-vs-AfricanAmerican |
2.2725998860551E-10 |
Normal-vs-Asian |
8.43560000000076E-05 |
Caucasian-vs-AfricanAmerican |
5.686400E-01 |
Caucasian-vs-Asian |
5.604000E-01 |
AfricanAmerican-vs-Asian |
6.518200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.81774603649865E-12 |
Normal-vs-Female |
3.21089999999469E-06 |
Male-vs-Female |
1.603840E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.45760000000029E-05 |
Normal-vs-Extreme_Weight |
3.15492076907731E-12 |
Normal-vs-Obese |
5.86670000357614E-08 |
Normal-vs-Extreme_Obese |
1.480340E-02 |
Normal_Weight-vs-Extreme_Weight |
7.270100E-02 |
Normal_Weight-vs-Obese |
6.408000E-01 |
Normal_Weight-vs-Extreme_Obese |
6.446400E-01 |
Extreme_Weight-vs-Obese |
1.304410E-01 |
Extreme_Weight-vs-Extreme_Obese |
6.052600E-01 |
Obese-vs-Extreme_Obese |
8.043200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.18370002267466E-09 |
Normal-vs-Age(41-60Yrs) |
3.66149999209142E-09 |
Normal-vs-Age(61-80Yrs) |
5.39424060974625E-12 |
Normal-vs-Age(81-100Yrs) |
1.801570E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.791600E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.001400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.765000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.190030E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.082400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.591200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
6.61692922676593E-14 |
Normal-VS-Type2 PRCC |
2.44619999999474E-05 |
Normal-VS-KIRP CIMP |
2.67939999998301E-06 |
Normal-VS-Unclassified PRCC |
1.46879999995964E-06 |
Type1 PRCC-VS-Type2 PRCC |
2.904200E-03 |
Type1 PRCC-VS-KIRP CIMP |
7.441000E-01 |
Type1 PRCC-VS-Unclassified PRCC |
2.172800E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.142360E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.611200E-01 |
KIRP CIMP-VS-Unclassified PRCC |
7.106800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.75980005515208E-09 |
Normal-vs-N1 |
2.20389999583404E-08 |
Normal-vs-N2 |
6.967200E-04 |
N0-vs-N1 |
8.546200E-01 |
N0-vs-N2 |
8.669800E-01 |
N1-vs-N2 |
7.415400E-01 |
|
|